ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2021

Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis.

Huiping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.